An agreement between the National Nanotechnology Centre (Nanotec), University of Tokyo and iCONM (Innovation Centre of NanoMedicine) will see increased use of nanomedicine technology for cancer therapy, as well as enhancing the expertise of a Thai research team for nanomaterial development in a close collaboration with Japan Bridgestone Corporation.